Ulthera Inc., developer of ultrasound technology to rejuvenate the skin, announced the recent completion of $10.5 million in Series C venture funding. The funding was led by New Enterprise Associates with participation by Apposite Capital LLP. The Ulthera® System, approved by the FDA for eyebrow lifting, combines traditional ultrasound imaging with focused ultrasound therapy to provide lifting and toning of the skin, including face and neck treatments and eyebrow lifts. “We look forward to building upon our first year of global commercial success by expanding our platform technology into a multitude of aesthetic and medical applications,” said Matthew E. Likens, President and CEO of Ulthera. Coverage of Ulthera on national television segments has raised awareness among millions of consumers, fueling demand for the treatment worldwide. Knobbe Martens has represented Ulthera in its intellectual property matters since 2008, with Orange County attorneys Dr. Salima Merani and Terry Tullis managing the portfolio.
Consistently ranked among the top intellectual property firms in the nation and worldwide, Knobbe Martens Olson & Bear LLP has over 275 lawyers and scientists nationwide and dedicates its practice to all aspects of intellectual property law including litigation. Knobbe Martens serves a diverse group of clients from multinational corporations to emerging businesses of all stages. The firm is headquartered in Orange County, California, with additional offices in Los Angeles, Riverside, San Francisco, Seattle and Washington, D.C., and enjoys an international reputation for excellence.
